Volume Outcome Relationships and Effects
1 other identifier
observational
30
1 country
1
Brief Summary
This is a retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with esophageal cancer than low-volume facilities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 15, 2020
CompletedFirst Submitted
Initial submission to the registry
April 27, 2022
CompletedFirst Posted
Study publicly available on registry
April 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 15, 2028
March 20, 2026
January 1, 2026
7 years
April 27, 2022
March 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Esophageal Cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities
Retrospective analysis to assess if high-volume hospital facilities experience greater or lesser rates of incidence in patients with Esophageal Cancer than low-volume facilities
through study completion, up to 18 months
Eligibility Criteria
The purpose of the study is to evaluate the outcomes of esophageal cancer resection in patients in high volume (more than 5 esophagectomy performed per year) and low volume (less than 5 esophagectomy performed per year) hospital facilities.
You may qualify if:
- esophageal cancer
You may not qualify if:
- No esophageal cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Richardson Medical Center
Richardson, Texas, 75082, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dhiresh Jeyarajah, MD
Methodist Health System
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2022
First Posted
April 2, 2024
Study Start
June 15, 2020
Primary Completion (Estimated)
June 15, 2027
Study Completion (Estimated)
June 15, 2028
Last Updated
March 20, 2026
Record last verified: 2026-01